abstract |
The present invention relates to optical pure quinazoline compound, the particularly compound of general formula (I), and contain the medicinal compositions of this compound for the treatment of significant quantity, and regulate the purposes in the medicine of c-erbB-2 and/or EGF-R protein tyrosine kinase activity relative disease in preparation treatment. |